Apontis Pharma AG Sustainability Reports
APONTIS PHARMA AG is a specialty pharmaceutical company focused on the development, promotion, and sale of Single Pills that combine multiple generic active ingredients in a single dosage form. Its portfolio primarily targets the treatment of cardiovascular and respiratory diseases in the German market.
Sector: Manufacturing
Country: Germany
Exchange: Deutsche Börse (Xetra)
LEI: 894500ETO1J6MR8PDF91
FIGI: BBG0107RVJL2
5 reports from 2020 to 2024
